Get started

Pharmastocks

Stock Analysis Report: Aurobindo Pharma Ltd.Overview: The chart presents a technical analysis of Aurobindo Pharma Ltd. on a daily timeframe. The stock shows a recovery pattern with a visible RSI divergence, indicating a potential bullish reversal. Key Observations: 1.RSI Divergence: A bullish divergence is identified as the price made lower lows while the RSI formed higher lows, signaling waning bearish momentum and the likelihood of an upward move. 2.Critical Support Levels: Immediate support is marked at ₹1,273.35, corresponding to the 200-day moving average. A strong base exists at ₹1,199.40 and ₹1,101.55, which acted as previous demand zones. 3.Potential Resistance Zones: Initial resistance levels are observed at ₹1,310.80 and ₹1,346.60. Major resistance is seen at ₹1,403.25 and ₹1,450.35, where the stock could face selling pressure. 4.Buying Strategy: Enter long positions only if the price stabilizes above ₹1,273.35, confirming support. Watch for a breakout above ₹1,310.80 for momentum trades targeting higher resistance levels. 5.Volume Analysis: Increased volume on recent upward moves supports the bullish sentiment. Monitor volume patterns for confirmation of breakouts or trend reversals. Conclusion: Aurobindo Pharma shows signs of a potential bullish reversal. Traders should closely observe the ₹1,273.35 support level and enter only upon confirmation. Targets are placed at ₹1,310.80, ₹1,346.60, and beyond. Implement proper risk management to account for potential volatility.
NSE:AUROPHARMALong
by AngshumanSaikia
Novartis | NVS | Long at $99.00As one of the largest pharmaceutical companies in the world, Novartis NYSE:NVS is poised to grow well into 2027. It's trading at a 17x P/E, earnings are forecast to grow 7% per year, it has low debt, and has been raising its dividend over the past few years (3.8%). The price on the daily chart is nearing the historical simple moving average line and may be poised for another move up. However, entry into the lower $90's or even $80's is still not off the table and, in my view, a great opportunity. Thus, at $99.00, NYSE:NVS is in a personal buy zone. Target #1 = $110.00 Target #2 = $120.00
NYSE:NVSLong
by WorthlessViews
Alkem Laboratories Ltd. (NSE: ALKEM)Technical Analysis and Key Levels 1.Current Price Action: Alkem Laboratories is trading at ₹5,484.40, testing a critical support zone (₹5,300–₹5,450) identified by historical price action and volume profile. 2.Resistance and Support Levels: Immediate Resistance: ₹5,811.55 (previous swing high). Key Resistance Zone: ₹6,000–₹6,346.55. A breakout above ₹6,346.55 can lead to fresh bullish momentum. Immediate Support: ₹5,323.60 (near-term support). Critical Support: ₹4,629.85, a major demand zone. Failure to hold this level could trigger further downside. 3.Volume Profile: High-Volume Node (HVN): Significant buying interest is observed around ₹5,450–₹5,800. Low-Volume Node (LVN): Below ₹5,300, liquidity decreases, increasing the risk of a sharp drop toward ₹4,629.85. 4.Moving Averages: The stock is currently hovering around the 50-day moving average, indicating short-term indecision. The 200-day moving average at ₹5,323.60 acts as crucial support for long-term trend analysis. 5.RSI Indicator: The RSI is neutral but leaning towards the oversold region, suggesting potential accumulation in this zone. A break below ₹5,323 could push RSI into bearish territory. 6.Key Observations: Nomura's Price Target Update: Nomura revised the price target to ₹6,097 (Neutral stance), close to the immediate resistance levels, which aligns with market consolidation. 7.Potential Scenarios: Bullish Case: Sustaining above ₹5,484.40 and breaking ₹5,811.55 may open doors for ₹6,346.55. Bearish Case: A decisive break below ₹5,323.60 could lead to ₹4,629.85. 8.Trading Strategy: For Bulls: Look for confirmation above ₹5,811.55 with increased volumes before entering long positions. For Bears: Short opportunities arise if the stock breaks and sustains below ₹5,323.60 with a target near ₹4,629.85.
NSE:ALKEMLong
by AngshumanSaikia
APOLLOHOSPITAL 240 MINS TIME FRAME - MY VIEW ONLYThe Structure looks good to us, waiting for this instrument to correct and then give us these opportunities as shown on this instrument (Price Chart). Note: Its my view only and its for educational purpose only. Only who has got knowledge about this strategy, will understand what to be done on this setup. its purely based on my technical analysis only (strategies). we don't focus on the short term moves, we look for only for Bullish or Bearish Impulsive moves on the setups after a good price action is formed as per the strategy. we never get into corrective moves. because it will test our patience and also it will be a bullish or a bearish trap. and try trade the big moves. we do not get into bullish or bearish traps. We anticipate and get into only big bullish or bearish moves (Impulsive Moves). Just ride the Bullish or Bearish Impulsive Move. Learn & Know the Complete Market Cycle. Buy Low and Sell High Concept. Buy at Cheaper Price and Sell at Expensive Price. Please keep your comments useful & respectful. Keep it simple, keep it Unique. Thanks for your support Tradelikemee Academy Saanjayy KG
BSE:APOLLOHOSPShort
by Tradelikemee
Globus Medical: Approaching resistance, is a breakthrough comingWeekly Chart ● The stock has tested the trendline resistance multiple times. ● Currently, it is trading just below this level. ● A breakout above this resistance is anticipated in the near future. ● Following the breakout, the price may increase. Daily Chart ● A Symmetrical Triangle pattern has formed. ● A strong breakout has taken place, supported by significant volume. ● The price is now set for a potential upward movement.
NYSE:GMEDLong
by NaranjCapital
S&P Pharmaceutical Sector: A Prescription for Growth● The S&P Pharmaceutical sector has great potential for growth. ● The weekly chart shows that after breaking out of the Symmetrical Triangle Pattern, the ETF had a short period of consolidation and is now ready for a rise. ● The daily chart also indicates a Cup & Handle Pattern, with the price trending upward post-breakout. As the industry revives, certain stocks are ready to achieve similar success Key stocks to watch: Hims & Hers NYSE:HIMS ● The price has broken the trendline resistance with high volume. ● More upward movement is likely to follow. Crinetics Pharmaceuticals NASDAQ:CRNX ● Mirrors HIMS' chart pattern. ● Poised for robust growth after breakout.
AMEX:XPHLong
by NaranjCapital
life high Let’s dive deeper into the breakdown and the **last 5 candles** for a more detailed explanation of the chart: ### **Breakout Analysis**: **Breakout Level**: The stock price had been **consolidating** just below the resistance level of **₹194.96** for a while. This resistance level corresponds to the previous high, forming a psychological barrier. **Volume Confirmation**: The breakout was accompanied by a **massive volume spike** (112 million shares), which is a clear indicator that there’s strong buying interest and confirms that the breakout is likely legitimate. **Uptrend Line**: The purple trendline connecting the higher lows suggests that this uptrend has been building steadily over time. When the price broke above the ₹194-₹195 resistance, it broke free from this consolidation phase. ### **Last 5 Candles Analysis** (Weekly Chart): 1. **First Candle** (Leftmost): **Type**: Large **bullish candle** 📈. **Action**: This candle was the first to **break above ₹194.96**, making it significant as it signals a breakout. The long body suggests strong upward momentum, with buyers stepping in at the ₹195 level and driving the price up. **Volume**: Volume was **strong**, suggesting a lot of participation during the breakout. 2. **Second Candle**: **Type**: **Small-bodied candle**, a bit of a **spinning top** or **doji-like** pattern 📊. **Action**: After the strong breakout, the price action showed **indecision**. This indicates the market is pausing after a large move up, possibly due to profit-taking or some hesitation among traders about further upside. **Volume**: The volume slightly decreased, confirming the market's hesitation. 3. **Third Candle**: **Type**: Another **bullish candle** 🔼 but smaller than the first. **Action**: This candle confirms that the breakout remains **intact** as the price is holding above the breakout level and moving slightly upward. The smaller body compared to the first candle suggests that the momentum may be cooling off but is still on the upside. **Volume**: Moderate volume suggests some interest, but it’s lower than the breakout candle, which is expected in a consolidation period. 4. **Fourth Candle**: **Type**: **Small bearish candle** 💬 with a shadow (wick). **Action**: This candle indicates a **small pullback** or retracement, which is common after a breakout. Some traders are likely locking in profits after the breakout. The lower wick shows that although the price pulled back, buyers stepped in again, preventing a deeper drop. **Volume**: Slightly lower volume, indicating consolidation, and the sellers didn’t have much control despite the pullback. 5. **Fifth Candle** (Rightmost, Current Candle): **Type**: **Large bullish candle** 📈 **Action**: This is the **most significant candle**, with a **16.20% price surge**, confirming that buyers are back in full force. The long body shows that the price jumped from₹186 to₹219.59, a very strong move. This candle signals the continuation of the breakout move, with no significant resistance in the way. **Volume**: **Massive volume** (112M), which is far higher than previous weeks, confirming that the breakout has strong participation, making the uptrend more likely to continue. ### **Breakout Strength & Continuation**: The strength of this breakout is validated by the combination of **price action** (breaking through resistance) and **volume confirmation** (high volume during the breakout). With such strong volume and the fact that the price is now clearly above the **₹195 resistance**, this suggests that the stock could continue its upward momentum towards the next major resistance around **₹240-245**. ### **What to Watch**: A **strong close** this week will confirm the breakout. If the price stays above the **₹195** level with continued higher volume, it suggests that the breakout will hold. **Pullbacks** are possible, but they may provide entry points if the price holds above the ₹195 level. --- ### **Summary of Breakout & Last 5 Candles**: **Breakout confirmed** at ₹195 with huge volume. The stock has entered a **strong bullish phase** with increasing buying pressure. The **last 5 candles** show initial hesitation, a small pullback, but a **huge bullish push** in the most recent candle. Let me know if you'd like more insights! 😊 no recommendation for buy and sell
NSE:PPLPHARMALong
by investigationofchart
Axsome Therapeutics - A Pennant Primed to RiseAxsome - NASDAQ:AXSM ✅In position since Feb 2023 with average price $50.00 per share. This is a long term 3 - 5 year hold. ✅ Current unrealized gain at 75% ✅ Stop Loss set at $63.80 for 50% of the position to ensure short term gain capture ⏳We awaiting increasing levels of volume (see the green zone). Volume moving into this zone would be ideal and demonstrate increased interest ⏳The On Balance Volume (OBV) has demonstrated that is consolidates in parallel channels and when it breaks out of them it signals price direction. We can watch the OBV for direction The chart still looks great and we are sitting in a nice profit position with short term profits guaranteed by a stop. The OBV will be key to watch. I still think this company is ripe for a buy out. Background of Axsome Therapeutics AXSM are a Small Bio-Pharma company with market cap of $4.24 Billon. In August 2022 Auvelity Anti-Depressants was FDA approved & is the only rapid-acting oral medicine for MDD with labelling describing statistically significant antidepressant efficacy by one week. AXSM received Breakthrough Therapy designation from the FDA for an Alzheimer's disease drug development and are at the NDA phase for developing a drug for acute treatment of migraine. AXSM are also developing a treatment for narcolepsy and separately for fibromyalgia. All in, AXSM's offerings are building momentum. They have developed the fastest acting anti-depressant drug and are bringing it to market, and have a four other drugs in development, all of which have a large patient base. The company would be ripe for a buyout. PUKA
NASDAQ:AXSMLong
by PukaCharts
1
DR. REDDY LABThe Structure looks good to us, waiting for this instrument to correct and then give us these opportunities as shown on this instrument (Price Chart). Note: Its my view only and its for educational purpose only. Only who has got knowledge about this strategy, will understand what to be done on this setup. its purely based on my technical analysis only (strategies). we don't focus on the short term moves, we look for only for Bullish or Bearish Impulsive moves on the setups after a good price action is formed as per the strategy. we never get into corrective moves. because it will test our patience and also it will be a bullish or a bearish trap. and try trade the big moves. we do not get into bullish or bearish traps. We anticipate and get into only big bullish or bearish moves (Impulsive Moves). Just ride the Bullish or Bearish Impulsive Move. Learn & Know the Complete Market Cycle. Buy Low and Sell High Concept. Buy at Cheaper Price and Sell at Expensive Price. Please keep your comments useful & respectful. Keep it simple, keep it Unique. Thanks for your support Tradelikemee Academy Saanjayy KG
NSE:DRREDDYShort
by Tradelikemee
Index to watchout for next week: Pharma Index. For the past few weeks we have been trying to understand how to use the performance of an index reflects in performance of stocks that are constituents of that particular index and vice versa. By catching the index that is on the verge of breaking out or has broken out during the week, we can plan our investment and trades around it to maximize our returns. We spoke about Bank Nifty, then IT Index. Both gave considerable returns in the last 2 /3 weeks. The index that look most interesting this week end is Pharma Index. Pharma index has given a powerful breakout and has closed above very important fibonacci resistance (20380) this week. The closing of Pharma index this week was 20453.85. The next 2 Fibonacci resistances for Nifty will be at 21013 and 21475. Supports for the Pharma index remain at 19936 and 19397. 19397 is a mega support which has a combined power of Fibonacci, Mid-channel and 50 days EMA. The stocks that constitute the Pharma index are: Lupin, Dr.Reddy's Lab, Torrent Pharma, Alkem Lab, Biocon, Divi's Lab, Sun Pharma, Cipla, Zydus Life and Aurobindo Pharma. Some Peripheral Pharma stocks can also be looked at for investment purpose. We are not giving a buy or sell call on any of these companies. This is just an educational article explaining the potential moves of Pharma Index, how it can move in either direction and what can be the technical reasons behind the same. Disclaimer: There is a chance of biases including confirmation bias, information bias, halo effect and anchoring bias in this write-up. Investment in stocks, derivatives and mutual funds is subject to market risks, please consult your investment advisor before taking financial decisions. The data, chart and other information provided above is for the purpose of analysis and is purely educational in nature. The names of the stocks or index levels mentioned in the article are for the purpose of education and analysis only. Purpose of this article is educational. Please do not consider this as a recommendation of any sorts.
NSE:CNXPHARMALong
by Happy_Candles_Investment
GILD will be selected for the new Tamiflu vaccine for Pandemic2It's no secret the elite are manufacturing pandemics to herd, destroy and remake society into a neofeudal system controlled by social credit scores. The next pandemic will be H1N1 which has already been shared within the news that milk in the markets has trace amounts of (no worry they say!). After the establishment rolls out bird-flu for everyone's summer bingo card - Gilead Sciences, the only company that manufactures Tamiflu with options, will be selected to mass create these new vaccines. The call options on this company are going crazy right now, July, August have a ton of OTM calls being bought, almost like someone is expecting this company to get the greenlight on something major. You could effectively buy .05 OTM calls on this company, but I'd wait a little longer. The TTM squeeze shows the last leg down is being finished. If the market's capitulate a little more, this would be a perfect time to buy those calls for this company.
NASDAQ:GILDLong
by EmptyEternity
1
LLY rides its success against obesity and diabetes LONGLLY shown on a daily chart has doubled in the past year with the introduction of new FDA approved drugs into the market. It has but out a series of favorable earnings reports with optimistic realistic guidance and glowing analysts' forecasts. It has done so without any volume pumps and just keeps grinding higher. This is because it is in the shadows of big technology stocks. Revenues consistently beat analysts' forecasts quarter after quarter. Institutions add small lots trying to preserve the price for future buys without any run-ups. I have done the same thing and I will continue to do so. While day trading biotechnology penny stocks, LLY along with UNH, PFE, and AZN is where the profits are parked for growth and compounding.
NYSE:LLYLong
by AwesomeAvani
1
Cup and Handle kind of Breakout on cards for Pharma Index. Technically Pharma index is on the verge of giving a cup and handle like breakout in addition to news of new COVID variant making waves. The Pharma index also looking very buoyant. If this particular index can give a closing above 16515 there can be an upsurge 16734 or even 17177 levels taking the index constituents higher along with it. Major companies in pharma index are Abbott, Cipla, Glaxo, Sanofi, Pfizer, Dr Reddy's, Lupin, Torrent Pharam, Ipca Labs, Sun Pharma, Aurobind Pharma, Natco Pharma, Granules India, Gland Pharma, Alkem, Biocon, Glenmark, Zydus Lifescience, Divi's lab, Laurus lab. Some companies good companies of Mid and Small cap pharma can also yield positive momentum. Post identification of a strong index what you can do is try to look at the charts of each constituent of the index individually and select the stocks with best EPS, PE ratio, Good Cash flow from operations, Revenue and Net Profit growing year on year and quarter on quarter. Remember that now all the stocks in an index will move equally some will move faster, some will move at the same pace, some will move slowly and some will not move at all or move negatively. You have to be smart in selection of your stocks from the particular index and you will surely be able to beat the market and Ace the art of investing. There are many Pharma related Mutual funds that can also be looked at. Disclaimer: Investment in stocks and mutual funds is subject to market risks, please consult your investment advisor before taking financial decisions. The data provided above is for the purpose of analysis and is purely educational in nature. The names of the stocks given in the above article and chart of IT Index is only for analysis. Purpose of this article is educational. Please do not consider this as a recommendation of any sorts.
NSE:CNXPHARMALong
by Happy_Candles_Investment
Pharma Sector and its components Daily Timeframe AnalysisPharma Sector and its components are in correction phase NSE:CNXPHARMA sectors NSE:DIVISLAB , NSE:SUNPHARMA , NSE:DRREDDY have created same structure as NSE:NIFTY NSE:DIVISLAB , NSE:SUNPHARMA , NSE:DRREDDY daily candle close below level. We can see all targets along with NSE:NIFTY , $NSE:CNXMETAL. Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
NSE:CNXPHARMAShort
by sugatmankar
Moderna Break of Major Support, Short PotentialThis is a Technical Analysis on Moderna (MRNA) on the 1 Week Timeframe. Current price action shows that we are currently in the process of breaking a MAJOR SUPPORT Zone. We held critical SUPPORT multiple times ABOVE the $115.00 level, for a span of about 26 months. Expressed by the GREEN circles. But notice we havent been able to successfully rally and stay above the "MAJOR RESISTANCE" line. Though the CURRENT candle has not yet closed, which it will end of trading session Monday, the 7th of August. This in my opinion is a critical development. If we CONFIRM below this $115 ish area, the lower range of about $82.00 of the ORANGE zone becomes more likely. The ORANGE zone, or price range between $115 and $82 has barely any market structure or in other words barely any candles. It would be easy for price to fall stright down, in my opinion. This can be an area to take a SHORT position. Another thing to notice since the BLOW of top, we have been forming a DESCENDING TRIANGLE. Its been forming since August 2021, this is NO JOKE. Measuring the target of the end point of descending triangle we get about a 75% drop target. Just remember it doesnt have to play out exactly but its something to consider and keep in the back of the mind. So just to mention: 1st Target = $82 ish area 2nd Target = $57- $47 range Last Target = Descending triangle measured target of $29 ( *Less likely for the time being) RSI has been: 1. printing Lower Highs 2. is currently below the Black Moving average, which i use as an indication of price moving down 3.Is currently in process of ALL TIME RSI LOW, provided we close this weeks candle at current RSI lvl. STOCH RSI -> Setting up for a BEARish cross. This if it occurs and we are below the MAJOR SUPPORT, bearish momentum can push price down. Lastly ADX & DI -> We have RED line cross above Green and pointing up. We need to observe this, this indicates also the BEARISH momentum is coming in. If the BLACK moving average curves up and starts moving towards the RED/GREEN line with RED being on top, this will indicate bearish momentum. CONCLUSION: We are at major cross roads for MRNA. If we don't have any buying occur during Mondays trading session, and we close below MAJOR SUPPORT, it may be time to SHORT MRNA. We have not had any luck trying to break and stay above the "MAJOR RESISTANCE" line. This, along with multiple touches on MAJOR SUPPORT, has made this WEAK (in my opinion). Short targets include the primary, secondary and descending triangle target levels. Indicators are also shaping up to support the current price action. At times like this, it is important to observe further clues of bearish activity, to be patient and take it one step at a time. Thank you for taking the time to read my analysis. Hope it helped keep you informed. Please do support my ideas by boosting, following me and commenting. Thanks again. If you have any questions, do reach out. Thank you again. DISCLAIMER: This is not financial advice, i am not a financial advisor. The thoughts expressed in the posts are my opinion and for educational purposes. When trading always spend majority of your time on risk management strategy.
NASDAQ:MRNAShort
by SafofAllTrades